Every Ingredient in Angry Lady, Every Dose, and What the Research Shows

The full formula, the exact milligrams, the human trial behind each one, and a plain account of the two we are still working on.

Angry Lady contains 9 clinically studied ingredients and dosages. Here they are, in milligrams, with the research each one rests on. Affron saffron extract 30 mg, red maca 1,000 mg, DIM 150 mg, black cohosh extract 80 mg, chasteberry (Vitex) 40 mg, vitamin D3 4,000 IU, magnesium glycinate 150 mg, zinc picolinate 15 mg, and BioPerine black pepper extract 5 mg.

We sell this product. That is a reason to read the numbers rather than our adjectives, so the numbers come first and the argument comes after.

Key takeaways

• Every active ingredient and its exact amount is listed below. There is no proprietary blend in this formula.
• Individual ingredients have supporting human research. The finished Angry Lady formula has not been studied as a formula. Those are different claims and we do not blur them.
• Three ingredients here have human trials with anger or irritability as a measured endpoint. That is unusual in this category, and it is why the formula looks the way it does.
• Two ingredients have unfinished business: red maca, where the answer depends on an extract ratio we are documenting, and black cohosh, where the evidence is genuinely mixed. Both have their own section.
• Disclosure alone is not unique. Several competitors publish their doses too. The argument is disclosure plus dose size plus breadth, together.

Why a milligram number is the only claim worth checking

A supplement label can say "clinically studied saffron extract" while containing a fraction of the amount any study used. The sentence stays true. The bottle stays ineffective at the thing the study measured.

This is why the phrase on our own label is nine clinically studied ingredients and dosages. The first half of that phrase is available to anyone. The second half is what a company either publishes or hides.

Some competitors hide it inside a proprietary blend. Happy Mammoth's Hormone Harmony label carries three of them, totaling 2,077 mg of plant material, and discloses the exact amount of exactly one thing: vitamin B6, at 1.7 mg. Amberen uses a proprietary menopause compound and discloses vitamin E at 5.04 mg. Bonafide Relizen lists a 320 mg cytoplasmic blend. Estroven Extra Strength lists a 200 mg balancing herbal blend. In each case the customer cannot check the arithmetic before she buys.

Worth being precise, because the opposite mistake is easy to make: Estroven Complete is a different product with no blend at all, built on a single active at 4 mg. It is narrow rather than hidden, and narrow is a legitimate way to build a supplement. The objection here is concealment, not simplicity.

We publish ours so she can.

The nine, with the research

Affron saffron extract, 30 mg

This is the strongest ingredient in the formula and the only one we would call well matched to its research. Three randomized placebo-controlled trials have tested 28 mg of Affron daily, which is within 2 mg of what is in this capsule, using the same branded, standardized extract rather than generic saffron.

The closest one to our customer: a 2026 trial in Frontiers in Nutrition of 86 women aged 50 to 70 with low mood and poor sleep, over 12 weeks. 48.8% of the saffron group reached a meaningful improvement against 25.6% on placebo (P = 0.026). (Lopresti and Smith, Frontiers in Nutrition, 2026)

A larger 2025 trial in The Journal of Nutrition gave 202 adults 28 mg daily for 12 weeks. On the DASS-21 depression subscale, 72.3% of the saffron group reached a clinically meaningful improvement against 54.3% on placebo (P = 0.010), with a small-to-moderate effect size (Cohen's d = 0.39). (Lopresti et al., The Journal of Nutrition, 2025;155(7):2300-2311)

Two things a careful reader should know. These trials were funded by the ingredient's manufacturer, with company employees among the authors. And the outcome they moved was mood. Saffron did not beat placebo on hot flashes or night sweats, and we will not imply that it did.

Red maca, 1,000 mg

Red maca is included for energy and drive. It is also the one ingredient where we are not yet able to give you a clean answer, because the comparison depends on the extract ratio. See the section on what we are still working on.

DIM, 150 mg

DIM (3,3'-diindolylmethane) is included to support estrogen metabolism. The honest position on DIM is that human research measures changes in estrogen metabolite ratios, which is a laboratory marker, rather than measuring how a woman feels. It is a mechanism ingredient. We include it on that basis and we do not attach symptom promises to it.

Black cohosh extract, 80 mg

This is the ingredient we are least able to defend, and you should hear it from us rather than from someone else.

Black cohosh is the most-marketed botanical in the menopause category. It also has a genuine regulatory standing that most coverage skips: the European Medicines Agency grants it well-established use, not merely traditional use, for relief of menopausal complaints including hot flushes. That is a real determination by a real regulator.

There is a positive trial worth naming. A three-arm placebo-controlled study of 166 women using the Ze 450 extract found the higher dose beat placebo by 17.0 points on the Kupperman Index, P<0.0001. A 2023 meta-analysis pooling 22 studies and 2,310 women found a small significant benefit for hot flashes.

And here is the complication we are not going to hide. Black cohosh doses in the European literature are stated as milligrams of dried rhizome, not milligrams of extract, and the two differ by roughly a factor of six. Remifemin's "20 mg tablet," for instance, contains about 2.5 mg of dry extract. The EMA defines the effective dose by extraction solvent and drug-extract ratio, and never by triterpene glycoside percentage at all.

Our label says 80 mg. Whether that is the extract or the rhizome equivalent determines whether we are aligned with the strongest positive trial or using a different preparation entirely. We have asked our manufacturer for the solvent and the extract ratio in writing, and we will publish the answer here. Until then we are not going to claim a hot flash benefit.

The honest counterweight, since we are showing our work: the large trials that measured hot flash frequency rather than severity are null. The Herbal Alternatives for Menopause study ran 12 months in 351 women and found nothing. Cochrane pooled hot flushes at a difference of 0.07 per day, which is nothing. The EMA's own assessment notes that no high-quality study reached significance specifically on hot flushes. The European positives are severity scales; the American nulls are frequency diaries. That may be the whole explanation, and it may not.

So we include it at a serious dose rather than a token one, and we do not tell you it will reduce your hot flashes, because the evidence does not support that. If hot flashes are your main symptom, the section below on where this is not your best option is the part of this page to read.

Chasteberry (Vitex), 40 mg

A randomized, double-blind, placebo-controlled trial of 52 menopausal women aged 48 to 58 found that Vitex reduced vasomotor symptom scores significantly more than placebo over 8 weeks (P < 0.0001). (Naseri et al., Korean Journal of Family Medicine, 2019;40(6):362-367)

40 mg is the standard studied dose for chasteberry. It is the amount specified by German Commission E and by ESCOP, the European scientific body on herbal medicine, and it is the dose used in placebo-controlled trials including one of 217 women and a surveillance study of over 1,600.

The trial worth knowing about measured anger as its own endpoint. On a visual analogue scale, anger fell 22.1 mm against 11.7 mm on placebo, P=0.001. Irritability fell 28.9 against 18.2, P=0.001. Slightly more than half the women on chasteberry responded, against about a quarter on placebo. (Schellenberg, BMJ, 2001;322(7279):134-137)

Two things to hold alongside that. The trial was funded by the extract's manufacturer. And it studied premenstrual syndrome, not menopause. The European Medicines Agency has said plainly that the data are not sufficient to support chasteberry for menopausal symptoms, because the controlled trials have not been done. We include it for the mood and irritability side, where the evidence is, and not for hot flashes.

Vitamin D3, 4,000 IU

4,000 IU is a meaningful supplemental amount, roughly ten times what a typical multivitamin carries. Worth stating plainly: the evidence that vitamin D improves mood in people who are not deficient is weak. If your levels are already sufficient, this ingredient is doing less for you than the label implies. A blood test tells you which you are, and that is a conversation for your clinician.

Magnesium glycinate, 150 mg

Form matters more here than almost anywhere else on the panel. Magnesium oxide, the cheapest and most common form, is absorbed relatively poorly. Glycinate is better absorbed and gentler on the stomach. Paying for 400 mg of the wrong form can deliver less usable magnesium than a smaller amount of the right one.

This is also our second flagged dose. See below.

Zinc picolinate, 15 mg

Picolinate is a well-absorbed form. 15 mg is a sensible daily supplemental amount. The mood research on zinc at this dose is thin, and we do not build a symptom claim on it.

BioPerine black pepper extract, 5 mg

BioPerine is a standardized piperine extract included to support absorption of the other ingredients. 5 mg is the amount used in bioavailability research. It does nothing on its own, which is the point.

The whole formula against the research, in one table

A brand whose position is disclosure does not get to publish only the flattering numbers. So here is every ingredient set against the trial that matches it, including the two we are still working on.

One note on how to read this, because it is the thing most people get wrong about botanicals. A milligram number is close to meaningless for a plant extract unless you also know the drug-extract ratio. 40 mg of a 10:1 extract is 400 mg of herb. 40 mg of dried herb is 40 mg of herb. Same number on the label, tenfold difference in the capsule. It is the first thing to ask about any botanical, ours included.

The parts we are still working on

Two honest gaps, and we would rather you hear them from us.

Red maca, 1,000 mg. Maca has been trialed across a wide range, from 300 mg of a concentrated extract in perimenopausal women up to 3.5 g of raw powder. Where our 1,000 mg sits in that range depends entirely on the extract ratio, and we are getting that documented from our manufacturer rather than guessing at it in public. At a 4:1 concentration it would exceed the gram-dose trials in root-equivalent terms. At 1:1 it would not. We will publish the answer here when we have it in writing.

Black cohosh, 80 mg. Not a dose problem, a units problem. European trials dose in milligrams of dried rhizome and ours is printed as 80 mg without saying which. Until our manufacturer confirms the solvent and the extract ratio, we cannot tell you whether our preparation matches the ones with positive trials behind them. The ingredient has EMA well-established-use standing; our specific extract is unmapped. We make no hot flash claim on it.

Two more limits worth stating. Vitamin D3 at 4,000 IU is nutritional repletion, not mood support: a trial of 18,353 adults over five years found no effect on depression. And DIM is a mechanism ingredient measured against laboratory markers rather than symptoms, so we make no symptom claim on it.

We publish all of this because we can. Every number on our label is checkable, which is the only reason we are able to tell you precisely where this formula is strong and where the work is not finished. A company that hides its doses inside a proprietary blend cannot say that about its own product, because it has never published the numbers that would let anyone find out.

Where this formula is not your best option

Four situations where something else has the stronger case.

If your symptoms are moderate to severe hot flashes and night sweats, menopausal hormone therapy has an evidence base that no supplement matches. That is not a close call and we are not going to argue it. Talk to a clinician about whether it is right for you. Some women use hormone-free support alongside prescribed therapy; that is a question for the clinician who prescribed it.

If you have one isolated symptom, a single targeted product will likely serve you better and cost less. A comprehensive formula is for a cluster.

If you want a product whose finished formula has its own clinical trial, Angry Lady does not have one. Bonafide Relizen and Amberen have studied their finished products. Those studies are company-sponsored and both products keep their doses hidden, which is its own problem, but the studies exist and ours does not. That is a genuine advantage they hold and you should weigh it.

If you are working from bloodwork with a clinician on a targeted protocol, stay with the protocol. This is for women who do not have one.

So what is the actual argument

Not transparency by itself. O Positiv's MENO core capsule, Bonafide Ristela, Thorne, and Ritual publish their amounts too. Disclosure is becoming table stakes, and that is good for everyone.

The argument is narrower than "our doses are bigger," and it is this: every active is disclosed, the formula covers the whole cluster rather than one symptom, the ingredients doing the most work are at the doses their trials used, and where the work is unfinished we say so on the same page. You now have that list. You cannot get it from a proprietary blend at any price, because the numbers were never published.

Whether that is worth it to you depends on what you want. If you want the largest possible dose of one thing, buy that one thing. If you want a company that shows its work, this is what showing the work looks like.

See the full label and every dose →

Frequently asked questions

Has the finished Angry Lady formula been clinically studied?
No. The individual ingredients have supporting human research, which is what this article documents. The finished product has not been through its own trial. Any brand telling you otherwise about their own multi-ingredient formula deserves to be asked for the link.

Which dose is your strongest?
Affron saffron at 30 mg. The trials used 28 mg of the same branded extract, one of them in 86 women aged 50 to 70, and the outcome they moved is the one most of our customers arrive with.

Which are your weakest?
Red maca, where the comparison depends on an extract ratio we are still documenting, and black cohosh, where the dose is fine but the evidence is mixed. Vitamin D3 and zinc are doing nutritional work rather than carrying a symptom claim, and DIM is a mechanism ingredient with no symptom trials behind it. The full accounting is in the section above.

Then why include the weaker ones at all?
Because a formula is a set of tradeoffs inside one capsule protocol, and a bottle large enough to hold every ingredient at its full trial dose is not a bottle anyone would take daily. That is a real constraint and it applies to every multi-ingredient product on the shelf. The difference is whether the company tells you where it landed.

Can I take this with hormone therapy?
Ask the clinician who prescribed your therapy. We are not able to answer that for your specific situation and we are not going to pretend we can.

How long before I would know if it is working?
The trials behind these ingredients ran 8 to 12 weeks. Judging a hormonal support supplement at two weeks is judging it before any of its evidence base had reported.

Who should not take this?
Anyone pregnant or breastfeeding, anyone with a hormone-sensitive condition, anyone with liver concerns (black cohosh warrants a specific conversation), and anyone on medication that might interact. In every one of those cases the answer is a clinician, not a supplement label.

You are not broken. You are unsupported.

Most women in this transition are not failing at something. They are running without support that nobody told them existed, and then evaluating products whose labels are built to prevent evaluation.

You should be able to check what you are buying. That is the whole reason this page exists, including the parts of it we would rather not have written.

Angry Lady publishes this article and sells the product described in it. Every dose listed is the amount in our formula. Every study cited is linked to its primary source so you can read it yourself. Our editorial standards, including how we select sources and how to report an error, are available on request at support@getangrylady.com.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Results referenced are from clinical studies on individual ingredients at their studied dosages and may not reflect individual results.